Amgen (AMGN) Treasury Shares (2009 - 2025)

Amgen's Treasury Shares history runs 16 years deep, the most recent figure standing at $1.2 million for Q4 2025.

• In Q4 2025, Treasury Shares fell 65.71% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.2 million (down 65.71% YoY), while the FY2025 annual figure was $1.2 million, down 65.71% from the prior year.
• Treasury Shares was $1.2 million for Q4 2025 at Amgen, down from $3.5 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $26.1 million in Q4 2022 to a low of $1.2 million in Q4 2025.
• Historically, Treasury Shares has averaged $10.4 million across 4 years, with a median of $4.6 million in 2021.
• Biggest YoY gain for Treasury Shares was 564.86% in 2022; the steepest drop was 67.39% in 2022.
• A 4-year view of Treasury Shares shows it stood at $21.7 million in 2021, then climbed by 20.28% to $26.1 million in 2022, then tumbled by 86.59% to $3.5 million in 2024, then tumbled by 65.71% to $1.2 million in 2025.
• The last three Treasury Shares figures came in at $1.2 million (Q4 2025), $3.5 million (Q4 2024), and $26.1 million (Q4 2022), per Business Quant data.